Where does Nuralogix Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nuralogix Corporation ranks #16,250 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nuralogix Corporation hold?

Nuralogix Corporation holds 18 US utility patents granted between 2018 and 2024, spanning 10 technology areas.

What is Nuralogix Corporation's Innovation Score?

Nuralogix Corporation has an Innovation Score of 37.5 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nuralogix Corporation focus on?

Nuralogix Corporation's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 18 patents, ranking #990 of 7,127 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Nuralogix Corporation's patent grant rate increasing or decreasing?

Nuralogix Corporation's recent grant velocity is +160% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Nuralogix Corporation's patents?

Nuralogix Corporation's patents average 19.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nuralogix Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Nuralogix Corporation

USPTO PatentsView assignee record - 18 granted patents across 10 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nuralogix ranks #16,250 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 10 technology areas.

#16,250
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.5/100): 19.2
avg claims per patent: +160%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16250 · Foreign Corporation #16,250 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #16,250/49,997
PHOTO-FINISH Nalu Medical
CPC-FOCUS A61B · 10 areas
INNOV-THIN 37.5/100
CLAIMS-RICH 19.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +160% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nalu Medical, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Nuralogix’s 37.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (27%) Velocity 4.7 pts (13%) Breadth 11.2 pts (30%) Claim depth 11.5 pts (31%)

Qualcomm Incorporated · highest

85
Nuralogix · this assignee

38
3D Lighting… · lowest

7

What this shows Nuralogix's Innovation Score is 37.5/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Nuralogix?

Each dot is one of Nuralogix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nuralogix’s own 19.2 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Nuralogix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Nuralogix's grants concentrate

Nuralogix Corporation is a focused PatentsView assignee: 10 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2018. By volume, Nuralogix sits between Nippon Valqua Industries, Ltd. and Nanjing Hydraulic Research Institute.

Nuralogix's three-year grant acceleration

Nuralogix Corporation shows 7 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nippon Valqua Ind…

18
Nira Dynamics AB

18
Nitoms

18
Novelmed Therapeu…

18
Nuvation BIO

18
NYX

18
Nalu Medical

18
Nanjing Hydraulic…

18
Nuralogix ◀

18

What this shows Nuralogix holds 18 patents at rank #16,226, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nuralogix

By rank, the assignees closest to #16,226 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Nuralogix's primary technology class.

Nuralogix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Nuralogix Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	5.6%
2019	4	22.2%
2020	5	27.8%
2021	1	5.6%
2022	3	16.7%
2023	2	11.1%
2024	2	11.1%

Which technologies does Nuralogix Corporation patent most?

A61B - DIAGNOSIS; SURGERY; Identification 18

G06N - Computing Arrangements Based ON Specific Computational Models 16

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 12

G06T - Image Data Processing OR Generation, IN General 10

G06V - Image OR Video Recognition OR Understanding 9

G06F - Electric Digital Data Processing 2

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 2

H04N - Pictorial Communication, e.g. Television 2

G08B - Signalling OR Calling SYSTEMS; Order TELEGRAPHS; Alarm Systems 2

G10L - Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding 2

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Nuralogix Corporation's patent record in context - here's where to go next.

Nuralogix Corporation's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #16,250 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nuralogix Corporation against Nippon Valqua Industries, Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.